肝脓肿致脓毒症合并糖尿病患者的临床特征及其预后

Clinical characteristics and prognosis of liver abscess-induced sepsis in patients with diabetes mellitus

  • 摘要:
    目的 分析肝脓肿致脓毒症合并糖尿病与未合并糖尿病患者的临床特征、病原学特性、治疗和预后,为临床诊断和治疗提供参考。
    方法 回顾性分析2020年1月—2024年6月临沂市中心医院住院的细菌性肝脓肿致脓毒症患者124例的临床资料,根据是否合并糖尿病,分为糖尿病组56例和非糖尿病组68例通过电子病历系统收集患者的临床资料,包括性别、年龄、体质量指数、基础疾病、症状体征、实验室检查指标、病原学结果、影像学特征、住院时间、治疗及转归,比较两组患者的临床特征及预后差异。
    结果 糖尿病组血小板计数为(150.80±65.08)×109/L,低于非糖尿病组,丙氨酸转氨酶、总胆红素、降钙素原分别为(169.53±56.99)U/L、(37.89±21.40)μmol/L、(8.98±5.16)ng/L,均高于非糖尿病组(均P<0.05)。糖尿病组发生单发脓肿比例(92.86%)高于非糖尿病组(P<0.001)。肝脓肿多发生于肝右叶(86例,69.35%),其次肝左叶(31例,25.00%),但两组患者在脓肿生长位置差异无统计学有意义。所有患者均行血液和(或)脓液培养,其中发现肺炎克雷伯菌94例(75.81%),其次为大肠埃希菌12例(9.67%),两组差异均无统计学意义。糖尿病组降钙素原恢复正常时间、住院费用分别为(9.46±2.51)d、(32 688.53±6 568.51)元,均长(高)于非糖尿病组(P<0.05)。
    结论 细菌性肝脓肿致脓毒症合并糖尿病患者以单发脓肿更多见,肺炎克雷伯菌感染率更高,若合并糖尿病更易进展为脓毒性休克,延长住院时间,增加医疗费用。积极控制血糖是细菌性肝脓肿合并脓毒症患者治疗的重要措施。

     

    Abstract:
    OBJECTIVE  To analyze the clinical features, etiological characteristics, treatment and prognosis of patients with liver abscess-induced sepsis, comparing those with and without diabetes mellitus, and to provide references for clinical diagnosis and treatment.
    METHODS  A retrospective analysis was conducted on the clinical data of 124 patients with bacterial liver abscess-induced sepsis admitted to Linyi Central Hospital from Jan. 2020 to Jun. 2024. Based on the presence of diabetes mellitus, patients were divided into a diabetes group (n=56) and a non-diabetes group (n=68). Clinical data were collected from the electronic medical record system, including sex, age, body mass index (BMI), underlying diseases, symptoms and signs, laboratory test indicators, etiological results, imaging characteristics, length of hospital stay, treatment and outcomes. Clinical features and prognosis were compared between the two groups.
    RESULTS  The platelet count in the diabetes group was (150.80±65.08)×109/L, which was lower than that in the non-diabetes group. Alanine aminotransferase, total bilirubin and procalcitonin levels were (169.53±56.99) U/L, (37.89±21.40) μmol/L and (8.98±5.16) ng/L, respectively, all higher than those in the non-diabetes group (all P<0.05). The proportion of patients with a solitary abscess in the diabetes group (92.86%) was higher than that in the non-diabetes group (P<0.001). Liver abscesses predominantly located in the right lobe (n=86, 69.35%), followed by the left lobe (n=31, 25.00%). However, no statistically significant difference was observed in abscess location between the two groups. Blood and/or pus cultures were performed for all patients, identifying Klebsiella pneumoniaen=94, 75.81%) and Escherichia colin=12, 9.67%), with no statistically significant differences between the two groups. The time to procalcitonin normalization and hospital costs in the diabetes group were (9.46±2.51) days and (32 688.53±6 568.51) RMB, respectively, both longer (higher) than those in the non-diabetes group (P<0.05).
    CONCLUSIONS  Patients with bacterial liver abscess-induced sepsis and diabetes mellitus more commonly present with a solitary abscess and have a higher infection rate with K. pneumoniae. These patients are more likely to progress to septic shock, have prolonged hospital stays, and incur higher medical costs. Active glycemic control is therefore an important measure in their management.

     

/

返回文章
返回